Followers | 10 |
Posts | 1467 |
Boards Moderated | 0 |
Alias Born | 07/16/2006 |
Saturday, February 28, 2015 5:46:48 PM
Top Institutional Holders
Holder
Shares
% Out
Value*
Reported
BlackRock Fund Advisors 1,179,960 2.09 3,209,491 Dec 31, 2014
Vanguard Group, Inc. (The) 1,110,560 1.96 3,020,723 Dec 31, 2014
Northern Trust Corporation 426,716 0.75 1,160,667 Dec 31, 2014
State Street Corporation 420,435 0.74 1,143,583 Dec 31, 2014
BlackRock Institutional Trust Company, N.A. 362,433 0.64 985,817 Dec 31, 2014
Geode Capital Management, LLC 210,570 0.37 572,750 Dec 31, 2014
KCG Holdings, Inc. 201,209 0.36 547,288 Dec 31, 2014
Bridgeway Capital Management, Inc. 197,500 0.35 537,200 Dec 31, 2014
Bank of New York Mellon Corporation 169,622 0.30 461,371 Dec 31, 2014
TIAA-CREF Investment Management, LLC 142,257 0.25 386,939 Dec 31, 2014
Top Mutual Fund Holders
Holder
Shares
% Out
Value*
from yahoo. All these are longs just waiting for some news.
Reported
iShares Russell 2000 ETF 729,753 1.29 1,984,928 Dec 31, 2014
Vanguard Total Stock Market Index Fund 635,591 1.12 1,906,773 Sep 30, 2014
Vanguard Extended Market Index Fund 344,847 0.61 1,034,541 Sep 30, 2014
iShares Russell 2000 Growth ETF 324,139 0.57 881,658 Dec 31, 2014
Spartan Extended Market Index Fund 143,363 0.25 389,947 Dec 31, 2014
College Retirement Equities Fund-Stock Account 120,437 0.21 361,311 Sep 30, 2014
iShares Micro Cap ETF 105,673 0.19 287,430 Dec 31, 2014
Bridgeway Funds Inc-Ultra Small Company Market Fund 100,000 0.18 300,000 Sep 30, 2014
Schwab Capital Trust-Small Cap Index Fund 58,800 0.10 224,028 Oct 31, 2014
AQR Funds-AQR Small Cap Momentum Fd 57,800 0.10 173,400 Sep 30, 2014
[url][/url][tag]insert-text-here[/tag]
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM